Description
RN Labs L-5MTHF is a pure and highly bioavailable form of folate.
Directly facilitating methyl group donation in the body, L-5MTHF may support numerous metabolic processes for optimum healing, development, detoxification, mental health and wellbeing.
Indications:
- Provides a methylated and metabolically active form of folate
- May bypasse the biochemical steps normally required by other folates
- Demonstrates greater metabolic activity than folic acid as a source of folate, with reduced potential for side effects
- May contribute to the normal growth of the foetus during pregnancy
- May support normal stress and cognitive function through healthy neurotransmitter production
- May support healthy red blood cell formation
- May play an important role in supporting healthy methylation
- May support healthy homocysteine levels
- May support healthy cardiovascular and vascular endothelial function
Each vegetarian capsule contains:
Calcium L-5-methyltetrahydrofolate |
550mcg |
Equiv. Levomefolic acid (L-5-MTHF) |
500mcg |
Excipients: Leucine, Tapioca Starch, Microcrystalline Cellulose, Colloidal Anhydrous Silica
For Practitioner Dispensing Only
If symptoms persist consult your healthcare practitioner.
Vitamin supplements should not replace a balanced diet.
Folate is considered safe during pregnancy.
Known Side Effects
In doses typically administered for therapeutic purposes, 5-MTHF is considered non-toxic. At doses over 10mg daily, gastrointestinal complaints, insomnia, irritability, and fatigue have been reported.
Whilst some concern exists that supplementation with high doses of folic acid could mask a vitamin B12 deficiency, supplementation with 5-MTHF appears to sidestep this potential problem. Since 5-MTHF can only be converted to 5,10-methylenetetrahydrofolate (involved in DNA synthesis) after participating in homocysteine recycling with vitamin B12, 5-MTHF will not mask a B12 deficiency.
Medication Interactions
The activity of 5-MTHF may affect, or be affected by, the presence of certain medications, including anticonvulsant and anti-inflammatory medications. Qualified consultation is advised when using these concomitantly.
TGA Listed product with Aust L 394270.
Download TGA Public Summary for TGA published information including excipients, which are listed under 'Other Ingredients'.
Download TGA Public Summary for TGA published information including excipients, which are listed under 'Other Ingredients'.